أعرض في EDS

Supplementary Figure 1 from GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers

التفاصيل البيبلوغرافية
العنوان: Supplementary Figure 1 from GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers
المؤلفون: Rakesh Kumar, Sridhar K. Rabindran, Stanley D. Chamberlain, Joseph W. Wilson, J. Brad Shotwell, Russell R. Lapierre, Sapna Suravajjala, Kenneth R. Maksimchuk, Richard R. Gontarek, Ryan G. Kruger, Kelly Anderson, Jingsong Yang, Melissa Dumble, Charity Atkins, Dominic Leperi, Qi Liu, Arthur Groy, Jason L. Rowand, Susan Korenchuk, Peter Sabbatini
بيانات النشر: American Association for Cancer Research (AACR), 2023.
سنة النشر: 2023
الوصف: Supplementary Figure 1. Cell cycle effects of GSK1838705A.
DOI: 10.1158/1535-7163.22485584
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35dbf19db7624f81e1b1bd2711932df6
https://doi.org/10.1158/1535-7163.22485584
Rights: OPEN
رقم الانضمام: edsair.doi.dedup.....35dbf19db7624f81e1b1bd2711932df6
قاعدة البيانات: OpenAIRE
الوصف
DOI:10.1158/1535-7163.22485584